Catheter News and Research RSS Feed - Catheter News and Research

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.
Novel document on ventricular arrhythmias published in EP Europace

Novel document on ventricular arrhythmias published in EP Europace

The first expert consensus on ventricular arrhythmias is published today. The novel document compiles current evidence on the diagnosis and management of ventricular arrhythmias and was agreed by international experts from three continents. [More]
ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

The first comprehensive ESC Guidelines on aortic diseases are published today. They are presented at ESC Congress 2014 by Task Force Chairpersons Professor Raimund Erbel (Germany) and Professor Victor Aboyans (France). [More]
Recommendations on arrhythmia management in ACS patients published in EP Europace

Recommendations on arrhythmia management in ACS patients published in EP Europace

The first multidisciplinary recommendations on the management of arrhythmias in patients with acute coronary syndromes (ACS) are published today in EP Europace. [More]
Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO (rivaroxaban) to include additional high-risk patient populations. [More]
Sequent Medical initiates patient enrollment in IDE pivotal trial of WEB Aneurysm Embolization System

Sequent Medical initiates patient enrollment in IDE pivotal trial of WEB Aneurysm Embolization System

Sequent Medical, Inc. announced today that it has initiated patient enrollment in an Investigational Device Exemption ("IDE") pivotal trial to evaluate the safety and effectiveness of the WEB Aneurysm Embolization System ("WEB"). [More]
New wireless monitoring sensor helps doctors and patients manage heart failure problems

New wireless monitoring sensor helps doctors and patients manage heart failure problems

Unexpected trips to the hospital are inconvenient and worrisome for anyone, but for congestive heart failure sufferers, they can be all too frequent. [More]
State highlights: Only 1/3 chose Medicaid plan in Fla.; Calif. Prop 46 money

State highlights: Only 1/3 chose Medicaid plan in Fla.; Calif. Prop 46 money

A selection of health policy stories from Florida, Oregon, California, New York, Missouri, Iowa, Illinois, Massachusetts, Minnesota and New Jersey. [More]
Electronic alerts reduce urinary tract infections in hospital patients with urinary catheters

Electronic alerts reduce urinary tract infections in hospital patients with urinary catheters

A Penn Medicine team has found that targeted automated alerts in electronic health records significantly reduce urinary tract infections in hospital patients with urinary catheters. In addition, when the design of the alert was simplified, the rate of improvement dramatically increased. [More]
Free fatty acids may be effective in treating catheter-related bloodstream infections

Free fatty acids may be effective in treating catheter-related bloodstream infections

Researchers at Rhode Island Hospital, Veterans Affair Medical Center in Providence and University of Rhode Island have found that a free fatty acid, made up of compounds similar to those naturally made in the body, may be as effective at fighting certain infections as antibiotics. [More]
Research leads to optimal design of alternative to open-heart surgery

Research leads to optimal design of alternative to open-heart surgery

University of Houston (UH) professor Suncica "Sunny" Canic is a mathematician, not a medical doctor, but her research could save the lives of heart patients. [More]
Regional anesthesia technique allows majority of patients to go home within hours of surgery

Regional anesthesia technique allows majority of patients to go home within hours of surgery

A recent study of an ultrasound-guided regional anesthesia technique, called femoral nerve block, shows that it leads to less opioid use and allows the majority of patients to go home within hours of surgery. [More]
Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’

Cardium announces review in Journal of Cardiovascular Pharmacology finds gene therapy for subset of heart disease patients ‘highly warranted’

Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) has announced the publication of a review article in the Journal of Cardiovascular Pharmacology that concludes a gene therapy product promoting the growth of blood vessels is “highly warranted” to treat about 1 million U.S. heart-disease patients and 6 million more worldwide who are either ineligible or poor candidates for traditional angioplasty, stent placement or bypass surgery. [More]

U.S. Neuromodulation, Neurovascular, Neurosurgical And Monitoring Device Market

Reportlinker.com announces that a new market research report is available in its catalogue: U.S. Neuromodulation, Neurovascular, Neurosurgical and Monitoring Device Market. [More]
Repurposed drug used to treat ovarian cancer gives positive results

Repurposed drug used to treat ovarian cancer gives positive results

A repurposed drug originally used to treat ovarian cancer saw positive results for patients with advanced peritoneal cancers during a phase I clinical trial at The University of Kansas Cancer Center. [More]

Lazarus Effect announces closing of $5 million financing

Lazarus Effect, a medical device company focused on the development of novel interventional devices to facilitate removal of blood clots, announced the closing of a $5 million financing. Proceeds from the financing will support EU commercialization of several approved Lazarus Effect devices, as well as regulatory filings for the Lazarus ReCover and Lazarus Cover in the United States. [More]

Codman Neuro introduces new ENVOY Guiding Catheters for neurovascular procedures

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the launch of the ENVOY DA XB Distal Access Guiding Catheter and the 7F ENVOY Guiding Catheter for neurovascular procedures. [More]
Catheter ablation improves quality of life for adults with atrial fibrillation

Catheter ablation improves quality of life for adults with atrial fibrillation

Adults who undergo a minimally invasive technique to treat atrial fibrillation are significantly less likely to die from a heart attack or heart failure, according to a long-term study by the University of Michigan Frankel Cardiovascular Center. [More]
Urinary microbiome altered in urge incontinence

Urinary microbiome altered in urge incontinence

The frequency and nature of bacteria in the urinary tract differs significantly between healthy women and those with urge incontinence, a US study demonstrates. [More]
Incisionless TAVR surgery cuts length of hospital stay by 30%

Incisionless TAVR surgery cuts length of hospital stay by 30%

New research from Penn Medicine shows that incisionless transcatheter aortic valve replacement (TAVR) surgery cuts length of hospital stay by 30 percent and has no impact on post-operative vascular complication rates when compared with conventional transfemoral TAVR, which requires an incision in the groin. [More]
Study aims at best way to treat deep vein thrombosis

Study aims at best way to treat deep vein thrombosis

Patients who have a clot in their legs and are considering whether to be treated with traditional blood-thinning medication or undergo a minimally-invasive catheter-based clot removal procedure should feel comfortable that there is no difference in death rates between the two treatments, although there are more bleeding risks with the catheter procedure, according to a study by Temple University School of Medicine researchers. [More]